BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 56.39% | 131.52% | -- | -- | -- |
| Gross Profit | -36.87% | -115.95% | -- | -- | -- |
| SG&A Expenses | 64.89% | 54.44% | 32.00% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.61% | 67.53% | 61.56% | -- | -- |
| Operating Income | -77.11% | -64.62% | -61.56% | -- | -- |
| Income Before Tax | -27.14% | -8.03% | -11.36% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.14% | -8.03% | -11.36% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.14% | -8.03% | -11.36% | -- | -- |
| EBIT | -77.11% | -64.62% | -61.56% | -- | -- |
| EBITDA | -77.35% | -64.81% | -61.75% | -- | -- |
| EPS Basic | 77.69% | 60.36% | 39.78% | -- | -- |
| Normalized Basic EPS | 73.21% | 52.96% | 28.94% | -- | -- |
| EPS Diluted | 77.69% | 60.36% | 39.78% | -- | -- |
| Normalized Diluted EPS | 73.21% | 52.96% | 28.94% | -- | -- |
| Average Basic Shares Outstanding | 1,552.36% | 1,051.67% | 541.04% | -- | -- |
| Average Diluted Shares Outstanding | 1,552.36% | 1,051.67% | 541.04% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |